Braxia Scientific Corp (BRAXF)
0.0024
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Braxia Scientific Net Income (Quarterly): -0.6663M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.6663M |
September 30, 2023 | -0.2033M |
June 30, 2023 | -0.5964M |
March 31, 2023 | -5.66M |
December 31, 2022 | -1.598M |
September 30, 2022 | -1.795M |
June 30, 2022 | -0.7582M |
March 31, 2022 | -5.374M |
December 31, 2021 | -2.001M |
Date | Value |
---|---|
September 30, 2021 | -1.358M |
June 30, 2021 | -0.8888M |
March 31, 2021 | -2.047M |
December 31, 2020 | -1.183M |
September 30, 2020 | -1.540M |
June 30, 2020 | -59.70M |
March 31, 2020 | -2.070M |
December 31, 2019 | -0.1125M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-59.70M
Minimum
Jun 2020
-0.1125M
Maximum
Dec 2019
-5.150M
Average
-1.540M
Median
Sep 2020
Net Income (Quarterly) Benchmarks
Acasti Pharma Inc | -2.617M |
Aurinia Pharmaceuticals Inc | 0.722M |
Edesa Biotech Inc | -1.668M |
Lexaria Bioscience Corp | -1.782M |
Xenon Pharmaceuticals Inc | -57.92M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 0.3617M |
Total Expenses (Quarterly) | 0.9914M |
EPS Diluted (Quarterly) | -0.0025 |
Enterprise Value | 0.6788M |
Gross Profit Margin (Quarterly) | 16.65% |
Profit Margin (Quarterly) | -184.2% |
Earnings Yield | -1.44K% |
Normalized Earnings Yield | -771.59 |